Asia-Pacific PDX models market is estimated to grow with a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for Asia-Pacific PDX models market are listed below;

Crown Bioscience Inc.
The Jackson Laboratory
Champion Oncology, Inc.
Charles River
Oncodesign
Wuxi AppTec
Horizon Discovery Group plc
Pharmatest Services
Hera Biolabs
EPO Berlin-Buch GmbH
Xentech
Urolead
Creative Animodel
EUROPDX
MI Bioresearch Inc
Aragen Bioscience

The market is further segmented into;
Type
Tumor Type
Application
End User


The Asia Pacific PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.
The Asia Pacific PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
The Asia Pacific PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
The Asia Pacific PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
Based on geography, the market is segmented into;
Japan
China
India
South Korea
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Covered in this report
The report covers the present scenario and the growth prospects of the Asia-Pacific PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.